Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
5 Ergebnisse für "gene" unter Roche Glycart AG
Линейка продуктов для анализа методами ИГХ/ISH в диагностике рака м...
... HER2 Dual ISH assay is concordant to FISH and reproducible in determining HER2 gene status in invasive ... of adopting different in situ hybridization technologies to assess HER2 gene amplification in breast ... gene status in invasive breast carcinoma. Poster presented at the ASCO Breast Cancer Symposium; 2011 ... organizational impact of adopting different in situ hybridization technologies to assess HER2 gene amplification ...
